ENTPD1 and neoplasm: Independently, increased mRNA expression of ENTPD1 (CD39) and NT5E (CD73) in the CD8− inflamed tumor subtype could signal an adenosine-rich TME (Antonioli et al., 2013), further contributing to CD8+ T cell exclusion in these tumors (Figures 6B and S6D).